Production (Stage)
Moleculin Biotech, Inc.
MBRX
$0.67
-$0.0201-2.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.48M | 2.16M | 2.17M | 2.06M | 2.39M |
| Depreciation & Amortization | 31.00K | 31.00K | 31.00K | 31.00K | 32.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.94M | 6.64M | 7.14M | 6.19M | 6.68M |
| Operating Income | -5.94M | -6.64M | -7.14M | -6.19M | -6.68M |
| Income Before Tax | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M |
| EBIT | -5.94M | -6.64M | -7.14M | -6.19M | -6.68M |
| EBITDA | -5.91M | -6.61M | -7.10M | -6.15M | -6.65M |
| EPS Basic | -0.69 | -0.37 | -2.85 | -1.70 | -2.02 |
| Normalized Basic EPS | -0.43 | -0.23 | -1.78 | -1.06 | -1.26 |
| EPS Diluted | -0.69 | -0.37 | -2.85 | -1.70 | -2.02 |
| Normalized Diluted EPS | -0.43 | -0.23 | -1.78 | -1.06 | -1.26 |
| Average Basic Shares Outstanding | 9.34M | 5.04M | 3.71M | 2.54M | 2.47M |
| Average Diluted Shares Outstanding | 9.34M | 5.04M | 3.71M | 2.54M | 2.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |